These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34894393)

  • 1. [Disturbance of lipid homeostasis in lysosomal lipase deficiency – pathomechanism, diagnosis and treatment].
    Lipiński P; Tylki-Szymańska A
    Postepy Biochem; 2021 Sep; 67(3):231-235. PubMed ID: 34894393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.
    Thelwall PE; Smith FE; Leavitt MC; Canty D; Hu W; Hollingsworth KG; Thoma C; Trenell MI; Taylor R; Rutkowski JV; Blamire AM; Quinn AG
    J Hepatol; 2013 Sep; 59(3):543-9. PubMed ID: 23624251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme replacement therapy in lysosomal acid lipase deficiency (LAL-D): a systematic literature review.
    Bashir A; Tiwari P; Duseja A
    Ther Adv Rare Dis; 2021; 2():26330040211026928. PubMed ID: 37181111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent insights into lysosomal acid lipase deficiency.
    Korbelius M; Kuentzel KB; Bradić I; Vujić N; Kratky D
    Trends Mol Med; 2023 Jun; 29(6):425-438. PubMed ID: 37028992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency.
    Maciejko JJ
    Am J Cardiovasc Drugs; 2017 Jun; 17(3):217-231. PubMed ID: 28197978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and metabolic profiling of patients with lysosomal acid lipase deficiency.
    Pullinger CR; Stock EO; Movsesyan I; Malloy MJ; Frost PH; Tripuraneni R; Quinn AG; Ishida BY; Schaefer EJ; Asztalos BF; Kane JP
    J Clin Lipidol; 2015; 9(5):716-26.e1. PubMed ID: 26350820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants.
    Pisciotta L; Tozzi G; Travaglini L; Taurisano R; Lucchi T; Indolfi G; Papadia F; Di Rocco M; D'Antiga L; Crock P; Vora K; Nightingale S; Michelakakis H; Garoufi A; Lykopoulou L; Bertolini S; Calandra S
    Atherosclerosis; 2017 Oct; 265():124-132. PubMed ID: 28881270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal Acid Lipase in Lipid Metabolism and Beyond.
    Li F; Zhang H
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):850-856. PubMed ID: 30866656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sebelipase alfa improves atherogenic biomarkers in adults and children with lysosomal acid lipase deficiency.
    Wilson DP; Friedman M; Marulkar S; Hamby T; Bruckert E
    J Clin Lipidol; 2018; 12(3):604-614. PubMed ID: 29628368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case of Lysosomal Acid Lipase Deficiency Confirmed by Response to Sebelipase Alfa Therapy.
    Shen JJ; Davis JL; Hong X; Laningham FH; Gelb MH; Kim GE
    J Pediatr Gastroenterol Nutr; 2020 Dec; 71(6):726-730. PubMed ID: 32740531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and functional characterization of human lysosomal acid lipase gene (LIPA) mutation responsible for cholesteryl ester storage disease (CESD) phenotype.
    Rajamohan F; Reyes AR; Ruangsiriluk W; Hoth LR; Han S; Caspers N; Tu M; Ward J; Kurumbail RG
    Protein Expr Purif; 2015 Jun; 110():22-9. PubMed ID: 25620107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage.
    Du H; Duanmu M; Witte D; Grabowski GA
    Hum Mol Genet; 1998 Sep; 7(9):1347-54. PubMed ID: 9700186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sebelipase alfa in children and adults with lysosomal acid lipase deficiency: Final results of the ARISE study.
    Burton BK; Feillet F; Furuya KN; Marulkar S; Balwani M
    J Hepatol; 2022 Mar; 76(3):577-587. PubMed ID: 34774639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic correction of lipid storage and growth arrest in wolman disease fibroblasts by gene transfer of lysosomal acid lipase.
    Tietge UJ; Sun G; Czarnecki S; Yu Q; Lohse P; Du H; Grabowski GA; Glick JM; Rader DJ
    Hum Gene Ther; 2001 Feb; 12(3):279-89. PubMed ID: 11177564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies.
    Vijay S; Brassier A; Ghosh A; Fecarotta S; Abel F; Marulkar S; Jones SA
    Orphanet J Rare Dis; 2021 Jan; 16(1):13. PubMed ID: 33407676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal acid lipase deficiency: wolman disease and cholesteryl ester storage disease.
    Tylki-Szymańska A; Jurecka A
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(1):99-106. PubMed ID: 24798600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended use of a selective inhibitor of acid lipase for the diagnosis of Wolman disease and cholesteryl ester storage disease.
    Civallero G; De Mari J; Bittar C; Burin M; Giugliani R
    Gene; 2014 Apr; 539(1):154-6. PubMed ID: 24508470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare cause of hepatomegaly and dyslipidemia: lysosomal acid lipase deficiency.
    Gürbüz BB; Güney İ; Bulut FD; Dilek O
    Turk J Pediatr; 2020; 62(5):831-835. PubMed ID: 33108087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and therapeutic management of children with lysosomal acid lipase deficiency (LAL-D). Review of the literature and own experience.
    Wierzbicka-Rucińska A; Jańczyk W; Ługowska A; Lebensztejn D; Socha P
    Dev Period Med; 2016; 20(3):212-215. PubMed ID: 27941191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of a patient with lysosomal acid lipase deficiency and first results after initiation of treatment with Sebelipase alfa: A case report.
    Soll D; Spira D; Hollstein T; Haberbosch L; Demuth I; Steinhagen-Thiessen E; Bobbert T; Spranger J; Kassner U
    Mol Genet Metab Rep; 2019 Sep; 20():100479. PubMed ID: 31249784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.